GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,473.50p
   
  • Change Today:
      10.50p
  • 52 Week High: 1,609.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,068.16m
  • Volume: 7,032,406
  • Market Cap: £59,944m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

GSK plans $30bn US investment as pharma faces tariff threat

By Frank Prenesti

Date: Wednesday 17 Sep 2025

(Sharecast News) - GSK has announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years, amid fears of tariffs being imposed on the pharma industry by US President Donald Trump, who is in the UK on a state visit.

GSK gepotidacin edges closer to landmark approval for gonorrhoea

By Iain Gilbert

Date: Monday 11 Aug 2025

(Sharecast News) - Drugmaker GSK moved closer to expanding its antibiotic portfolio on Monday, after US regulators accepted its application to review gepotidacin as a potential oral treatment for gonorrhoea.

GSK and CureVac secure $740m payout in mRNA patent settlement

By Iain Gilbert

Date: Friday 08 Aug 2025

(Sharecast News) - Drugmaker GSK said on Friday that it had reached a settlement, alongside CureVac, to resolve long-running patent litigation with BioNTech and Pfizer over mRNA-based COVID-19 vaccines.

London close: Stocks fall on Trump's latest tari... 01-Aug-2025 ShareCast
London close: Stocks mixed on robust US data, ea... 30-Jul-2025 ShareCast
GSK Q2 revenues grow, expects FY performance to ... 30-Jul-2025 ShareCast
London close: Stocks reverse gains to finish lower 28-Jul-2025 ShareCast
GSK and Hengrui unveil development deal worth up... 28-Jul-2025 ShareCast
London close: FTSE finishes week just shy of 9,000 18-Jul-2025 ShareCast
FDA rejects overall benefit/risk profile of GSK'... 18-Jul-2025 ShareCast
US FDA approves new format of GSK's Shingrix 17-Jul-2025 ShareCast
US FDA to review GSK bid to extend use of respir... 14-Jul-2025 ShareCast
EMA accepts marketing authorisation application ... 23-Jun-2025 ShareCast
GSK hoping to expand Arexvy usage in Japan 20-Jun-2025 ShareCast
GSK's RSV vaccine accepted for regulatory review... 13-Jun-2025 ShareCast
Berenberg downgrades GSK to 'hold' ahead of prod... 03-Jun-2025 ShareCast
GSK's linerixibat to be reviewed by US FDA 02-Jun-2025 ShareCast
GSK, Spero UTI drug trial ends early after meeti... 28-May-2025 ShareCast
GSK's COPD treatment approved by FDA 23-May-2025 ShareCast
GSK's blood cancer treatment approved in Japan 19-May-2025 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,473.50p
Change Today 10.50p
% Change 0.72 %
52 Week High 1,609.50
52 Week Low 1,264.00
Volume 7,032,406
Shares Issued 4,068.16m
Market Cap £59,944m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 14
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 14-Aug-25 15-May-25
Paid 09-Oct-25 10-Jul-25
Amount 16.00p 16.00p

Trades for 17-Sep-2025

Time Volume / Share Price
17:35 783,624 @ 1,464.00p
17:35 783,624 @ 1,464.00p
15:57 0 @ 1,468.00p
15:57 1 @ 1,468.00p
15:57 1 @ 1,468.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page